Topics Include:
Costs and Burdens of Civil Discovery
The Final Rule: FDA's Safety Reporting Requirements for Investigational New Drug Applications
Mensing: Preemption or Not? Plantiffs' Creative Ways Around the Decision.
Please see full publication below for more information.